Systemic sclerosis is a rare and chronic connective tissue disease with a multifaceted
pathogenesis characterised by heterogeneous multi-organ clinical manifestations. Every year, …

Background Systemic sclerosis-associated interstitial lung disease (ILD) carries a high
mortality risk; expert guidance is required to aid early recognition and treatment. We aimed to …

Caveolin-1 plays an important role in the regulation of TGF-β signaling and participates in
the pathogenesis of systemic sclerosis and idiopathic pulmonary fibrosis. Restoration of …

The role played by T1 IFN and its regulatory genes in SSc is becoming increasingly evident
and strikingly similar to the role observed in SLE. This observation, together with the benefit …

The aim was to update the 2009 European League against Rheumatism (EULAR)
recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic …

Background— Recent studies indicate that T-cell activation may play an important role in
the pathophysiology of acute coronary syndromes (ACS). However, although those studies …

Objective Recent studies have implicated caveolin 1 in the regulation of transforming growth
factor β (TGFβ) downstream signaling. Given the crucial role of TGFβ in the pathogenesis of …

Background Preliminary criteria for the very early diagnosis of systemic sclerosis (VEDOSS)
have been previously proposed to identify signs and symptoms in patients with Raynaud's …

Recently, we reported that human breast cancer-associated fibroblasts show functional
inactivation of the retinoblastoma (RB) tumor suppressor and down-regulation of caveolin-1 (Cav-…

Background Skin involvement is of major prognostic value in systemic sclerosis (SSc) and
often the primary outcome in clinical trials. Nevertheless, an objective, validated biomarker of …